Adverse Reactions of Weight Loss Products in the Market

Adverse Reactions of Weight Loss Products in the Market

Adverse reactions linked to weight loss products involve multiple organ systems, with illegally added ingredients posing severe health risks. Below is a scientific analysis of major adverse effects:  

Cardiovascular Risks

1. Myocardial Infarction & Stroke

   Sibutramine (a central nervous system inhibitor), a common illegal additive, suppresses appetite but significantly increases cardiovascular risks. Studies show long-term use elevates blood pressure and heart rate, potentially leading to myocardial infarction, stroke, or sudden death.  

2. Pulmonary Hypertension & Heart Valve Disease

   Phentermine (a controlled psychotropic drug) suppresses appetite via sympathomimetic effects but may trigger pulmonary hypertension and heart valve damage, requiring prolonged medical intervention. 

Gastrointestinal Damage

1. Gastrointestinal Dysfunction

   Orlistat (a lipase inhibitor) causes oily stools, steatorrhea, and fecal incontinence, severely impacting quality of life.  

   Illegal laxatives (e.g., senna, rhubarb) induce diarrhea and bloating. Chronic use leads to electrolyte imbalances and intestinal dysfunction.  

2. Hepatic & Renal Injury

   Undisclosed chemicals (e.g., diuretics, thyroid hormones) increase metabolic burden on the liver and kidneys, resulting in organ damage.  

Metabolic & Endocrine Disorders

1. Nutrient Malabsorption

   Appetite suppressants (e.g., amfepramone) disrupt central nervous signaling, causing malnutrition, anemia, and osteoporosis.  

2. Hormonal Imbalance

   Illegally added **fluoxetine** (antidepressant) or **semaglutide** (GLP-1 agonist) may disrupt insulin secretion, leading to hypoglycemia or thyroid dysfunction.  

Neurological & Psychiatric Effects

1. Insomnia & Mood Disorders

   Caffeine or stimulant-containing products trigger anxiety, insomnia, depression, and even delirium or mania.  

2. Drug Dependence

   Addictive substances (e.g., diazepam) cause withdrawal symptoms like headaches and emotional instability upon discontinuation.  

Other Risks

1.Weight Rebound & Metabolic Adaptation

   Post-drug weight loss may lower basal metabolic rate, leading to rapid weight regain exceeding initial levels.  

Consumer Recommendations

1. Avoid High-Risk Ingredients: Steer clear of products containing sibutramine, phentermine, or amfepramone.

2. Adopt Science-Based Strategies: Prioritize dietary adjustments (e.g., fiber-rich diets) and exercise.

The safety of weight loss products depends on ingredient legitimacy. Consumers must recognize risks and avoid prioritizing short-term results over long-term health. While regulators continue cracking down on illegal additives, market risks persist. Sustainable weight management through science remains paramount.